Navigation Links
GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
Date:11/10/2008

s are included in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission.

Third Quarter Operational Highlights:

* On October 22, 2008, Dr. Robert McNally, GeoVax's President and CEO,

was the featured interview on the Wall St. Network's 3-Minute Press

Show, a daily program that features in-depth interviews with public

company executives. The interview may be viewed in its entirety at

http://www.tv.wallst.net/r/3-minute-press/Bob-McNally-GOVX-BB/306/1207.

* On October 31, 2008, an additional interview with Dr. McNally was

published by CEOCFO Interviews & News

(http://www.ceocfointerviews.com). Also, GeoVax was prominently

featured in a special Biotechnology supplement to the November issue

of Harvard Business Review, sponsored by the Michigan Economic

Development Corp (MEDC).

* On October 20, 2008, GeoVax announced shipment of both components

(DNA and MVA) of its AIDS vaccine to the HIV Vaccine Trials Network

(HVTN) pharmacy, for use in the upcoming Phase 2a human clinical

trial. GeoVax also announced the submission of a Biological Master

File Amendment to the U.S. Food and Drug Administration (FDA) for

review of the manufacturing data for the product shipped to HVTN.

The Phase 2a trial will be conducted by the HVTN and will involve

225 healthy volunteers from the United States and South America. The

trial will further evaluate the safety and immunogenicity of the

GeoVax preventative vaccine (vaccine administered prior to infection

with the HIV virus) and will broaden the base of safety and

immunogenicit
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update
2. U.S. Government Awards $15 Million Grant to GeoVax Labs HIV/AIDS Vaccine Program
3. GeoVax Further Strengthens Management Team
4. GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update
5. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
6. GeoVax Presents Data at AIDS Vaccine 2008 Conference
7. GeoVaxs DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... (NYSE: MDT ) has submitted a pre-market ... (FDA) for the use of Medtronic,s SynchroMed ® ... catheter) for use with United Therapeutics, Remodulin ® ...
(Date:12/24/2014)... AUSTIN, Texas , Dec. 24, 2014  Vermillion, ... focused on gynecologic disease, announced today that the ... investors including Oracle Investment Management, Jack W. ... directors. Total proceeds were $10.5 million, before offering ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 “Preparative ... Gas, HPLC, Flash), Consumables (Columns, Solvents, Buffers, Valves, ... Food & Agriculture) - Forecasts to 2019” provides ... challenges, opportunities, current market trends, and strategies impacting ...
(Date:12/24/2014)... Boston, MA (PRWEB) December 23, 2014 Earlier ... James L. Sherley, director of the Adult Stem Cell Technology ... overlooked and under appreciated unique property of adult tissue stem ... Misunderstood in the Past, Important for the Future,” embodied the ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
... June 15 ERT (Nasdaq: ERES ), a leading ... to the biopharmaceutical, medical device, and related industries, announced today that ... Booth #507 at the 45th Annual DIA Meeting, 21-25 June 2009 ... showcasing, for the first time since its successful Company rebranding exercise, ...
... Professionals , , VOORHEES, N.J., June 15 ... infection (CDI) has been changing. This trend may ... or other factors. It is critical for healthcare professionals ... pathogen and apply evidence-based principles for diagnosis, treatment, and ...
... Is Nearly Completed , , BEIJING, June 15 /PRNewswire-Asia/ -- ... developer and provider of vaccines in China, announced today that it ... produce a virus antigen. , , Sinovac received the ... June 8, 2009 and started the H1N1 vaccine production on the ...
Cached Biology Technology:ERT to Showcase Its Clinical Trials Portfolio at DIA's 45th Annual Meeting at Booth #507 2ERT to Showcase Its Clinical Trials Portfolio at DIA's 45th Annual Meeting at Booth #507 3Clostridium difficile Infection: Strategic Approaches for Better Outcomes 2Sinovac Completes Construction of H1N1 Virus Seed Bank 2Sinovac Completes Construction of H1N1 Virus Seed Bank 3
(Date:1/22/2015)... , Jan. 13, 2015  Today, FreeWavz ( www.FreeWavz.com ... its crowdfunding campaign on Fundable, https://www.fundable.com/freewavz . ... of production capacity to meet customer demand. ... - http://photos.prnewswire.com/prnh/20150113/168790 Invented ...
(Date:1/22/2015)... Jan. 16, 2015  A man-made form of insulin delivered ... mental capabilities in adults with mild cognitive impairment and ... by researchers at Wake Forest Baptist Medical Center. ... amnesic mild cognitive impairment (MCI) or mild to moderate ...
(Date:1/22/2015)...  Analyst Report Issued by Small Cap IR. In 2011, Nilson ... transactions at merchants on the leading payment cards rose to ... debit, and prepaid cards reached 6.54 billion.  Eight million credit ... usage in 2012, and credit and debit card fraud resulted ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
... countries has identified one gene and a previously unidentified region ... may contribute to a child's chances of having autism. , ... with two or more children who have autism, were published ... Europe and North America who make up the Autism Genome ...
... Many commercially prized fish from the depths of the ... species' ability to recover is constrained by the fishes' ... experts said today at the annual meeting of the ... the fish species living at depths greater than 500 ...
... identified a novel gene mutation that causes X-linked mental ... diagnosis, according to an article to be published electronically ... of Human Genetics. , Investigators F. Lucy Raymond ... UK) and Patrick S. Tarpey (Wellcome Trust Sanger Institute, ...
Cached Biology News:Largest genomic search finds genes that may contribute to autism 2Largest genomic search finds genes that may contribute to autism 3Long-lived deep-sea fishes imperiled by technology, overfishing 2Long-lived deep-sea fishes imperiled by technology, overfishing 3Severe mental retardation gene mutation identified 2
Applications: Epitope mapping, Mapping protein-protein contacts, Identification of enzyme substrates/inhibitors, Identification of receptor agonists/antagonists...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Request Info...
Biology Products: